Breast Cancer Clinical Trial
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of enzalutamide alone and in combination with anastrozole, or exemestane, or fulvestrant in patients with incurable breast cancer.
Eligibility Criteria
Inclusion Criteria:
Histologically confirmed breast cancer with accompanying pathology report;
Submit unstained representative tumor specimen, either as a paraffin block (preferred) or ≥ 10 unstained slides
Received at least 2 lines of systemic therapy in the advanced setting (for enzalutamide alone arm only);
Eastern Cooperative Oncology Group performance (ECOG) status of 0 or 1;
Estimated life expectancy of at least 3 months
Exclusion Criteria:
Severe concurrent disease, infection, or comorbidity that, in the judgment of the Investigator, would make the patient inappropriate for enrollment;
Pregnant or lactating;
Known or suspected brain metastasis or leptomeningeal disease;
History of another malignancy within the previous 5 years other than curatively treated in situ carcinomas;
For patients who are enrolled to receive enzalutamide plus anastrozole or exemestane or fulvestrant must not have received tamoxifen or any medication known to be a potent CYP3A4 inducer or inhibitor.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 12 Locations for this study
Aurora Colorado, 80045, United States
Aurora Colorado, 80045, United States
Aurora Colorado, 80045, United States
Enfield Connecticut, 06082, United States
Sarasota Florida, 34232, United States
Detroit Michigan, 48201, United States
Corinth Mississippi, 38834, United States
Southaven Mississippi, 38671, United States
New York New York, 10022, United States
New York New York, 10065, United States
New York New York, 10065, United States
New York New York, 10065, United States
Germantown Tennessee, 38138, United States
Memphis Tennessee, 38104, United States
Memphis Tennessee, 38120, United States
Nashville Tennessee, 37203, United States
Nashville Tennessee, 37203, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.